SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-016448
Filing Date
2019-08-13
Accepted
2019-08-13 08:31:20
Documents
58
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atos20190630_10q.htm 10-Q 631055
2 EXHIBIT 31.1 ex_151030.htm EX-31.1 11562
3 EXHIBIT 31.2 ex_151031.htm EX-31.2 12122
4 EXHIBIT 32.1 ex_151032.htm EX-32.1 6118
5 EXHIBIT 32.2 ex_151033.htm EX-32.2 6667
  Complete submission text file 0001437749-19-016448.txt   3518311

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT atos-20190630.xml EX-101.INS 649282
7 XBRL TAXONOMY EXTENSION SCHEMA atos-20190630.xsd EX-101.SCH 41250
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atos-20190630_cal.xml EX-101.CAL 31157
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atos-20190630_def.xml EX-101.DEF 271800
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE atos-20190630_lab.xml EX-101.LAB 239803
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atos-20190630_pre.xml EX-101.PRE 296452
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA GENETICS INC (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35610 | Film No.: 191018310
SIC: 2834 Pharmaceutical Preparations